Compounded Semaglutide

GLP-1s are clinically proven medications that work with your body’s natural biology to support meaningful, sustainable weight loss. They mimic a hormone your body already produces—helping regulate appetite, stabilize blood sugar, and create a stronger sense of fullness after meals. This makes it easier to reduce calorie intake without relying on intense restriction or willpower alone.

At AltrX, we use GLP-1 therapies like semaglutide and tirzepatide to create a safer, smarter, and more effective path to weight management. These treatments are guided by licensed clinicians and tailored to your individual goals, giving you a science-backed foundation for long-term results and better overall health.

Yes. Clinical trials have demonstrated significant effectiveness—patients taking semaglutide lost an average of 12-15% of their body weight over 68 weeks. The medication works by mimicking your body's natural GLP-1 hormone, helping you feel fuller longer and reducing appetite naturally.

Results vary by individual, but when combined with lifestyle modifications and clinical guidance, GLP-1 medications like semaglutide have consistently shown meaningful, sustainable weight loss outcomes in peer-reviewed studies.

Semaglutide activates GLP-1 receptors in the brain and pancreas. This activation slows gastric emptying (keeping you fuller longer), enhances insulin secretion in response to meals, reduces glucagon release (stabilizing blood sugar), and decreases appetite signals in the brain.

The result is a multi-pathway approach to weight management that addresses both the hormonal and neurological factors driving hunger and metabolism—making it easier to maintain a calorie deficit without constant hunger or cravings.

Most people notice reduced appetite within the first few days. Food cravings diminish, portions feel more satisfying, and the urge to snack between meals decreases naturally. Many describe feeling comfortably full after smaller meals.

Common initial side effects include mild nausea, occasional bloating, or changes in digestion—these typically subside within 2-4 weeks as your body adjusts. Your clinician will start you on a low dose and gradually increase it to minimize discomfort while maximizing effectiveness.

Administration: Once-weekly subcutaneous injection (abdomen, thigh, or upper arm)
Dosing: Starts at 0.25mg weekly for 4 weeks, gradually increasing to maintenance doses between 1.0mg-2.4mg based on individual response and tolerability
Storage: Refrigerate before first use; can be kept at room temperature for up to 56 days after opening
Compounded by: Licensed U.S.-based compounding pharmacies following FDA guidelines